Pfizer and Moderna are expecting $32 billion and $19 billion, respectively, in COVID-19 vaccine sales this year, CNBC reported March 3.
Read the full post on Becker's Hospital Review - Healthcare News
Pfizer, Moderna expect $51B in vaccine sales in 2022
